Somu Subramaniam is Director & 10% Owner at Ventyx Biosciences, Inc. (VTYX). They have made 14 open-market trades across 2 companies since 2015, most recently 2026-03-04.
CIK 0001508910
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 14 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 46% | 54% | 62% |
| Avg Move | +0.4% | -10.7% | -15.0% |
| Scored | 13 | 13 | 13 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VTYX | SELL | 2023-10-09 | 2023-10-11 | $30.03 | $3.0M | -22.7% | -88.1% | -86.9% |
| VTYX | SELL | 2023-09-18 | 2023-09-20 | $37.81 | $4.3M | -10.6% | -50.7% | -93.9% |
| VTYX | SELL | 2023-07-28 | 2023-08-01 | $37.59 | $835K | -8.7% | -8.4% | -60.7% |
| VTYX | SELL | 2023-07-11 | 2023-07-13 | $37.55 | $2.4M | -0.0% | -9.2% | -42.8% |
| VTYX | SELL | 2023-07-07 | 2023-07-19 | $35.23 | $7.0M | +2.2% | -14.6% | -51.8% |
| VTYX | SELL | 2023-07-03 | 2023-07-06 | $39.00 | $10.5M | -2.4% | -10.8% | -23.1% |
| VTYX | SELL | 2023-06-14 | 2023-06-16 | $35.08 | $1.8M | +0.9% | +12.6% | +10.2% |
| VTYX | SELL | 2023-06-06 | 2023-06-08 | $35.62 | $2.7M | -3.9% | +6.6% | -5.7% |
| VTYX | SELL | 2023-04-21 | 2023-04-25 | $38.54 | $7.7M | +4.9% | -11.2% | -4.4% |
| VTYX | SELL | 2023-04-12 | 2023-04-14 | $30.22 | $6.0M | +17.1% | +15.0% | +13.1% |
| VTYX | SELL | 2022-12-15 | 2022-12-19 | $33.28 | $20.0M | +4.9% | +7.6% | +21.1% |
| VTYX | SELL | 2022-11-30 | 2022-12-02 | $29.01 | $15.8M | +18.4% | +2.9% | +60.3% |
| VTYX | SELL | 2022-11-07 | 2022-11-09 | $29.08 | $229K | +5.2% | +8.6% | +69.8% |
| ICAD | SELL | 2015-03-11 | 2015-03-13 | $9.23 | $469K | -26.7% | +0.6% | +0.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.